In Young Hwang

Hwang In Young

  • Research Assistant Professor, Department of Biochemistry
Joint Appointment(s)
  • Principal Investigator, NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI)
Academic Qualifications
  • Bachelor of Science (Hons), University of Auckland¬†
  • PhD, University of Auckland
Research Interest(s)
  • Synthetic Biology, Microbiome Engineering, Gut Microbiota, Mammalian Cell Engineering
Recent Publications
  • 1. Lee, H. L., Shen, H., Hwang, I. Y., Ling, H., Yew, W. S., Lee, Y. S., & Chang, M. W. (2018). Targeted approaches for in situ gut microbiome manipulation. Genes, 9(7). doi:10.3390/genes9070351.
  • 2. Hwang, I. Y., Koh, E., Wong, A., March, J. C., Bentley, W. E., Lee, Y. S., & Chang, M. W. (2017). Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models. NATURE COMMUNICATIONS, 8, 11 pages. doi:10.1038/ncomms15028.
  • 3. Hwang, I. Y., Koh, E., Kim, H. R., Yew, W. S., & Chang, M. W. (2016). Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria. DRUG RESISTANCE UPDATES, 27, 59-71. doi:10.1016/j.drup.2016.06.002.
  • 4. Ho, C. L., Hwang, I. Y., Loh, K., & Chang, M. W. (2015). Matrix-immobilized yeast for large-scale production of recombinant human lactoferrin. MEDCHEMCOMM, 6(3), 486-491. doi:10.1039/c4md00537f.
  • 5. Hwang, I. Y., Tan, M. H., Koh, E., Ho, C. L., Poh, C. L., & Chang, M. W. (2014). Reprogramming Microbes to Be Pathogen-Seeking Killers. ACS SYNTHETIC BIOLOGY, 3(4), 228-237. doi:10.1021/sb400077j.